We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Carving Ligaments Alleviates Spinal Stenosis Pain

By HospiMedica International staff writers
Posted on 13 Aug 2008
Researchers at Massachusetts General Hospital (MGH, Boston, MA, USA) performed a minimally invasive lumbar decompression (MILD) procedure under radiological guidance on ten patients. More...
Neurointerventional practitioners worked through a metal cannula, which was inserted through a small incision in the skin directly at the sight of the problem area. The practitioners then removed the bone--a procedure known as a laminotomy--and afterwards sculpted the enlarged ligaments that compressed the nerve roots, using a special device named Vertos placed inside the cannula. Because this minimally invasive procedure allows practitioners to remove targeted portions of the bone, MILD has the advantage of protecting against the destabilization of the spine during the procedure. As with other minimally invasive treatments, patients also benefit from local anesthesia, as well as same- or next-day discharge. The ten patients at MGH were followed under an internal review board (IRB)-approved protocol designed to assess improvement of pain and disability with commonly used measurement instruments, as well as review narcotic intake. At six weeks post-treatment, the mean pain score decreased 90% and the mean disability score improved 84%, compared to baseline. Additionally, all 10 patients discontinued narcotics use for pain. The study was presented at the Society of Neurointerventional Surgery (SNIS) annual meeting, held during July 2008, in Lake Tahoe (CA, USA). The Vertos device, a product of Vertos Medical (San Jose, CA, USA), has been approved by the U.S. Food and Drug Administration (FDA).

"The beauty of this procedure is that we have the opportunity to restore quality of life to hundreds of thousands of patients who are affected by LSS with an incision far smaller than a dime,” said study presenter Joshua Hirsch, M.D., director of interventional neuroradiology and endovascular neurosurgery and chief of minimally invasive spine surgery at MGH. "It is revolutionary therapies like this one that are giving neurointerventional practitioners the opportunity to change the entire landscape of patient care.”

LSS is a narrowing of the spinal canal in the lower back, known as the lumbar area. This narrowing occurs when bone and ligament growth restricts the canal, squeezing and irritating the nerves that branch out from the spinal cord. This compression causes patients to experience low back pain, leg fatigue and pain, and in severe cases, a significant reduced capacity for physical activity, including walking.

Related Links:
Massachusetts General Hospital
Vertos Medical


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Pressure Guidewire
SavvyWire
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.